Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $110,300 |
Sells | 61 | $36,539,205 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Nov 2023 18:02 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 02 Nov 2023 | Sale | 918 | 29.95 | 27,494 | D |
22 Mar 2024 16:52 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 20 Mar 2024 | Sale | 714 | 43.69 | 31,195 | D |
28 Jun 2024 17:31 | CRNX | Crinetics Pharmaceuticals Inc | KNIGHT JEFF E. | Chief Operating Officer | 26 Jun 2024 | Sale | 956 | 44.38 | 42,427 | D |
19 Dec 2022 17:11 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 15 Dec 2022 | Sale | 3,126 | 16 | 50,016 | D |
12 Sep 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 10 Sep 2024 | Sale | 1,035 | 51.5 | 53,302 | D |
05 Dec 2022 17:28 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 01 Dec 2022 | Sale | 3,126 | 17.84 | 55,768 | D |
19 Jan 2023 16:28 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 17 Jan 2023 | Sale | 3,126 | 18 | 56,268 | D |
05 Jan 2023 16:23 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 03 Jan 2023 | Sale | 3,126 | 18.35 | 57,362 | D |
03 Nov 2022 16:35 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 01 Nov 2022 | Sale | 3,126 | 18.52 | 57,894 | D |
17 Nov 2022 16:46 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 15 Nov 2022 | Sale | 3,126 | 18.72 | 58,519 | D |
03 Feb 2023 16:30 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 01 Feb 2023 | Sale | 3,126 | 19.59 | 61,238 | D |
29 Nov 2023 16:31 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 27 Nov 2023 | Sale | 3,000 | 31.84 | 95,520 | D |
13 Dec 2023 16:44 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 11 Dec 2023 | Sale | 3,000 | 32.87 | 98,610 | D |
26 Mar 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | KNIGHT JEFF E. | Chief Operating Officer | 22 Mar 2024 | Sale | 2,359 | 45.39 | 107,075 | D |
27 Dec 2023 17:20 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 26 Dec 2023 | Sale | 3,000 | 35.89 | 107,670 | D |
09 Jun 2023 08:00 | CRNX | Crinetics Pharmaceuticals Inc | VIVALDI COELHO ROGERIO | Director | 08 Jun 2023 | Purchase | 5,000 | 22.06 | 110,300 | D |
26 Jan 2024 17:50 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jan 2024 | Sale | 3,000 | 37.26 | 111,780 | D |
12 Jan 2024 16:12 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 10 Jan 2024 | Sale | 3,000 | 37.65 | 112,950 | D |
11 Jun 2024 16:35 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 10 Jun 2024 | Sale | 3,000 | 43.86 | 131,580 | D |
05 Apr 2023 19:12 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Development Officer | 05 Apr 2023 | Sale | 8,212 | 16.15 | 132,624 | D |
26 Jun 2024 16:32 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jun 2024 | Sale | 3,000 | 45.37 | 136,110 | D |
30 May 2024 16:28 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 28 May 2024 | Sale | 3,000 | 47.49 | 142,470 | D |
14 Aug 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 12 Aug 2024 | Sale | 3,000 | 47.68 | 143,040 | D |
12 Jul 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 10 Jul 2024 | Sale | 3,000 | 48.55 | 145,650 | D |
14 May 2024 18:29 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 10 May 2024 | Sale | 3,000 | 49.43 | 148,290 | D |
28 Aug 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 26 Aug 2024 | Sale | 3,000 | 53.19 | 159,570 | D |
26 Jul 2024 16:38 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jul 2024 | Sale | 3,000 | 53.43 | 160,290 | D |
27 Jan 2023 16:26 | CRNX | Crinetics Pharmaceuticals Inc | BETZ STEPHEN F. | Chief Scientific Officer | 25 Jan 2023 | Sale | 8,336 | 21.07 | 175,640 | D |
22 Mar 2024 16:52 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 20 Mar 2024 | Sale | 4,375 | 45.89 | 200,769 | D |
19 Oct 2023 17:01 | CRNX | Crinetics Pharmaceuticals Inc | KRASNER ALAN SETH | Chief Medical Officer | 17 Oct 2023 | Sale | 7,000 | 30 | 210,000 | D |
21 Jun 2023 17:32 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 20 Jun 2023 | Sale | 10,922 | 19.96 | 218,003 | D |
13 Jul 2023 16:56 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 12 Jul 2023 | Sale | 11,459 | 20.17 | 231,128 | I |
03 Nov 2023 19:38 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 01 Nov 2023 | Sale | 10,000 | 28.75 | 287,500 | D |
13 Jul 2023 16:56 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 13 Jul 2023 | Sale | 14,157 | 20.35 | 288,095 | I |
20 Mar 2024 18:32 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 19 Mar 2024 | Sale | 6,942 | 42.91 | 297,881 | D |
22 Dec 2023 18:45 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 21 Dec 2023 | Sale | 9,583 | 34.57 | 331,284 | D |
04 Jan 2024 16:43 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 02 Jan 2024 | Sale | 10,000 | 35.47 | 354,700 | D |
21 Jun 2023 17:32 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 20 Jun 2023 | Sale | 20,000 | 19.97 | 399,400 | D |
22 Mar 2024 16:52 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 20 Mar 2024 | Sale | 10,000 | 43.28 | 432,800 | D |
25 Jun 2024 17:03 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 24 Jun 2024 | Sale | 9,500 | 45.73 | 434,435 | D |
13 Jul 2023 16:56 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 11 Jul 2023 | Sale | 24,384 | 20.14 | 491,094 | I |
04 Jan 2024 16:45 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 03 Jan 2024 | Sale | 14,375 | 35 | 503,125 | D |
22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 12,500 | 43.57 | 544,625 | D |
22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 12,500 | 43.57 | 544,625 | D |
17 Apr 2024 16:36 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 15 Apr 2024 | Sale | 14,375 | 44.47 | 639,256 | D |
05 Jul 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 03 Jul 2024 | Sale | 14,375 | 44.87 | 645,006 | D |
09 Jul 2024 18:04 | CRNX | Crinetics Pharmaceuticals Inc | HASSARD JAMES | Chief Commercial Officer | 05 Jul 2024 | Sale | 15,000 | 44.08 | 661,200 | D |
24 Jun 2024 17:08 | CRNX | Crinetics Pharmaceuticals Inc | HASSARD JAMES | Chief Commercial Officer | 21 Jun 2024 | Sale | 15,000 | 44.66 | 669,900 | D |
22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 17,500 | 43.58 | 762,650 | D |
07 Oct 2024 07:55 | CRNX | Crinetics Pharmaceuticals Inc | PIZZUTI DANA | Chief Med and Dev Officer | 03 Oct 2024 | Sale | 14,375 | 54.63 | 785,306 | D |
22 Mar 2024 16:31 | CRNX | Crinetics Pharmaceuticals Inc | FUST MATTHEW K | Director | 20 Mar 2024 | Sale | 17,500 | 45.5 | 796,250 | D |
02 Apr 2024 16:35 | CRNX | Crinetics Pharmaceuticals Inc | OKEY STEPHANIE | Director | 28 Mar 2024 | Sale | 17,500 | 46.38 | 811,650 | D |
26 Jul 2024 16:24 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 25 Jul 2024 | Sale | 19,056 | 53.88 | 1,026,737 | D |
21 Jun 2023 17:27 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 16 Jun 2023 | Sale | 50,000 | 20.81 | 1,040,500 | I |
30 Sep 2024 17:01 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 26 Sep 2024 | Sale | 25,000 | 51.11 | 1,277,750 | D |
26 Mar 2024 16:30 | CRNX | Crinetics Pharmaceuticals Inc | KNIGHT JEFF E. | Chief Operating Officer | 22 Mar 2024 | Sale | 30,000 | 44.22 | 1,326,600 | D |
17 Jul 2024 17:14 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 15 Jul 2024 | Sale | 25,000 | 55 | 1,375,000 | D |
02 Jul 2024 16:32 | CRNX | Crinetics Pharmaceuticals Inc | WILSON MARC | CFO | 28 Jun 2024 | Sale | 32,129 | 43.61 | 1,401,146 | D |
17 Jul 2024 17:35 | CRNX | Crinetics Pharmaceuticals Inc | KNIGHT JEFF E. | Chief Operating Officer | 15 Jul 2024 | Sale | 27,000 | 55 | 1,485,000 | D |
08 Apr 2024 17:09 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 04 Apr 2024 | Sale | 40,951 | 49.17 | 2,013,561 | D |
10 May 2024 16:57 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 08 May 2024 | Sale | 107,448 | 49.4 | 5,307,931 | D |
06 Nov 2023 18:02 | CRNX | Crinetics Pharmaceuticals Inc | STRUTHERS RICHARD SCOTT | President & CEO | 03 Nov 2023 | Sale | 199,082 | 30.56 | 6,083,946 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)